ERBB2 and carcinoma: HER2-low carcinomas were diagnosed more frequently among individuals older than 50 years in contrast to the HER2–0 carcinomas (61.8% vs. 54.4%, P <0.001), and at an older median age (53 years vs. 51 years, P <0.001).